Though similar studies in osteosarcoma are rare, chemotherapeutic drugs can modulate death receptors (DRs) on osteosarcoma cells, which may make them more sensitive to Fas-mediated NK cell cytotoxicity. This evidence concerns the gene FAS and osteosarcoma.